Breaking News Instant updates and real-time market news.

2023-02-03 16:06:08 BRX Brixmor $23.54 / -0.35 (-1.47%) 16:06 02/03/23 02/03 16:06 02/03/23 16:06	Brixmor chair John Schreiber to retire, Crosland named next chair Brixmor Property Group announced that John G. Schreiber, the chair of the company's board of directors, will retire from the Board at the end of his current term, which will conclude as of the adjournment of the 2023 Annual Meeting of the company's Stockholders. Schreiber has served as chair of the Board since the company's initial public offering in 2013. Sheryl M. Crosland, a current independent director, will replace Schreiber as chair of the Board effective as of his retirement. "John's vision, wisdom and strategic leadership have been immensely valuable to the Board and management and have been a critical part of our success," commented James Taylor, CEO and President. "We are grateful for John's many contributions, for his unerring judgment, for his incisive wit, and for his service and dedication to our Company and our stockholders. We are a better company for having had the benefit of working with John. We thank John and wish him the very best. We are excited to have Sheryl assume the role of Chair and look forward to benefitting from her capable leadership and deep industry experience."	14 Feb

2023-02-03 16:06:08

BRX

Brixmor

$23.54 / -0.35 (-1.47%)

16:06

02/03/23

02/03

16:06

02/03/23

16:06

Brixmor chair John Schreiber to retire, Crosland named next chair

Brixmor Property Group announced that John G. Schreiber, the chair of the company's board of directors, will retire from the Board at the end of his current term, which will conclude as of the adjournment of the 2023 Annual Meeting of the company's Stockholders. Schreiber has served as chair of the Board since the company's initial public offering in 2013. Sheryl M. Crosland, a current independent director, will replace Schreiber as chair of the Board effective as of his retirement. "John's vision, wisdom and strategic leadership have been immensely valuable to the Board and management and have been a critical part of our success," commented James Taylor, CEO and President. "We are grateful for John's many contributions, for his unerring judgment, for his incisive wit, and for his service and dedication to our Company and our stockholders. We are a better company for having had the benefit of working with John. We thank John and wish him the very best. We are excited to have Sheryl assume the role of Chair and look forward to benefitting from her capable leadership and deep industry experience."

14
Feb

OTHER BREAKING NEWS FROM THE FLY

Initiation	Intellia Therapeutics initiated with an Outperform at Bernstein » 05:01 03/21/23 03/21 05:01 03/21/23 05:01 NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) Bernstein initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) 03/02/23 Intellia Therapeutics announces FDA clearance of IND for NTLA-2002 01/26/23 Cathie Wood's ARK Investment bought 195K shares of Intellia Therapeutics today 01/11/23 Intellia awarded innovation passport in UK for NTLA-2002 01/05/23 Intellia Therapeutics highlights strategic priorities, milestones for 2023 NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) 03/13/23 BMO Capital Intellia Therapeutics upgraded to Outperform from Market Perform at BMO Capital 03/10/23 Stifel Stifel says SVB fallout 'appears limited' across firm's biotech coverage 02/24/23 Chardan Intellia Therapeutics price target lowered to $111 from $129 at Chardan 02/24/23 Baird Intellia Therapeutics price target lowered to $42 from $58 at Baird NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) 02/23/23 Intellia Therapeutics reports Q4 EPS ($1.40), consensus ($1.39) 11/03/22 Intellia Therapeutics reports Q3 EPS ($1.49), consensus ($1.28) 01 Dec NTLA Intellia Therapeutics $38.25 / -1.58 (-3.97%) 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/11/22 Sell these stocks now, proven algorithm says 09/23/22 Sell these stocks now, proven algorithm says 09/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Initiation	Ionis Pharmaceuticals initiated with an Underperform at Bernstein » 05:00 03/21/23 03/21 05:00 03/21/23 05:00 IONS Ionis Pharmaceuticals $35.57 / +0.39 (+1.11%) Bernstein analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings IONS Ionis Pharmaceuticals $35.57 / +0.39 (+1.11%) 03/07/23 Ionis Pharmaceuticals: FDA accepts NDA for eplontersen 02/01/23 Ionis Pharmaceuticals: GSK advances bepirovirsen into Phase 3 development 01/31/23 Ionis Pharmaceuticals receives FDA Fast Track designation for olezarsen 01/23/23 Ionis confirms FDA to hold advisory committee meeting on tofersen NDA IONS Ionis Pharmaceuticals $35.57 / +0.39 (+1.11%) 02/23/23 SVB Securities Ionis Pharmaceuticals price target lowered to $27 from $34 at SVB Securities 02/23/23 Barclays Ionis Pharmaceuticals price target lowered to $40 from $44 at Barclays 01/19/23 Piper Sandler Ionis Pharmaceuticals price target raised to $62 from $60 at Piper Sandler 12/21/22 Guggenheim Ionis 2023 revenue estimate raised at Guggenheim IONS Ionis Pharmaceuticals $35.57 / +0.39 (+1.11%) 02/22/23 Ionis Pharmaceuticals sees FY23 revenue $575M, consensus $672.18M 02/22/23 Ionis Pharmaceuticals reports Q4 EPS (37c), consensus (92c) 11/09/22 Ionis Pharmaceuticals backs 2022 revenue above $575M, consensus $594.45M 11/09/22 Ionis Pharmaceuticals reports Q3 EPS (33c), consensus (74c)
Initiation	Alnylam initiated with an Outperform at Bernstein » 04:59 03/21/23 03/21 04:59 03/21/23 04:59 ALNY Alnylam $187.47 / +2.01 (+1.08%) Bernstein analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ALNY Alnylam $187.47 / +2.01 (+1.08%) 03/09/23 Alnylam and Medison Pharma expand multi-regional partnership to Eastern Europe 02/21/23 Alnylam announces FDA acceptance of patisiran sNDA 01/05/23 Alnylam names Amy Schulman board chair 12/21/22 Alnylam submits CTA application for type 2 diabetes treatment ALN-KHK ALNY Alnylam $187.47 / +2.01 (+1.08%) 02/24/23 Canaccord Alnylam price target lowered to $291 from $310 at Canaccord 02/24/23 Citi Alnylam price target lowered to $265 from $270 at Citi 02/24/23 SVB Securities SVB downgrades Moderna to Underperform as COVID boom reverses 02/21/23 EF Hutton Alnylam initiated with a Buy at EF Hutton ALNY Alnylam $187.47 / +2.01 (+1.08%) 02/23/23 Alnylam sees FY23 revenue $1.2B-$1.285B, consensus $1.48B 02/23/23 Alnylam reports Q4 EPS ($1.39), consensus ($1.90) 10/27/22 Alnylam reports Q3 EPS ($1.58), consensus ($1.77) ALNY Alnylam $187.47 / +2.01 (+1.08%) 02/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 Biotech Alert: Searches spiking for these stocks today 10/08/23 PDUFA Date for Patisiran (Onpattro)
Initiation	BioMarin initiated with an Underperform at Bernstein » 04:58 03/21/23 03/21 04:58 03/21/23 04:58 BMRN BioMarin $92.36 / +0.725 (+0.79%) Bernstein initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BMRN BioMarin $92.36 / +0.725 (+0.79%) 03/07/23 BioMarin: FDA accepts sNDA to expand use of VOXZOGO for injection 03/06/23 BioMarin says FDA extends review of BLA for Roctavian 01/08/23 BioMarin announces data from follow up from Phase 3 GENEr8-1 study of ROCTAVIAN 01/03/23 BioMarin's application for Voxzogo in achondroplasia validated by EMA BMRN BioMarin $92.36 / +0.725 (+0.79%) 03/09/23 Chardan Tenaya Therapeutics price target lowered to $24 from $28 at Chardan 02/28/23 Stifel BioMarin price target raised to $118 from $114 at Stifel 02/28/23 Wedbush BioMarin price target lowered to $74 from $83 at Wedbush 02/28/23 Canaccord BioMarin price target lowered to $112 from $119 at Canaccord BMRN BioMarin $92.36 / +0.725 (+0.79%) 02/27/23 BioMarin sees FY23 EPS under new method of $1.80-$2.05, consensus $1.61 02/27/23 BioMarin reports Q4 EPS (0c), consensus (7c) 02/27/23 Notable companies reporting after market close 10/26/22 BioMarin backs FY22 revenue view $2.06B-$2.16B, consensus $2.12B BMRN BioMarin $92.36 / +0.725 (+0.79%) 02/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/25/22 Biotech Alert: Searches spiking for these stocks today 11/23/22 What You Missed On Wall Street On Wednesday 06/30/23 PDUFA Date for Roctavian--Extended 10/21/23 PDUFA Date for VOXZOGO
Initiation	Vertex Pharmaceuticals initiated with an Outperform at Bernstein » 04:57 03/21/23 03/21 04:57 03/21/23 04:57 VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) Bernstein analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 03/09/23 Vertex says FDA clears IND for VX-264 with potential to treat type 1 diabetes 03/09/23 Vertex says FDA clears IND for VX-264 with potential to treat type 1 diabetes 03/01/23 ImmunoGen announces license agreement with Vertex Pharmaceuticals 02/09/23 Entrada Therapeutics closes agreement with Vertex VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 03/01/23 Guggenheim Immunogen confident in early Elahere launch, says Guggenheim 02/22/23 Chardan Crispr Therapeutics price target lowered to $123 from $153 at Chardan 02/08/23 SVB Securities Vertex Pharmaceuticals price target lowered to $365 from $374 at SVB Securities 02/08/23 H.C. Wainwright Vertex Pharmaceuticals price target raised to $325 from $300 at H.C. Wainwright VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 02/07/23 Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B 02/07/23 Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51 02/07/23 Notable companies reporting after market close 10/27/22 Vertex Pharmaceuticals raises 2022 revenue to $8.8B-$8.9B from $8.6B-$8.9B VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 02/07/23 Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 03/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/30/22 What You Missed On Wall Street This Morning 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/31/22 Biotech Alert: Searches spiking for these stocks today VRTX Vertex Pharmaceuticals $298.91 / +3.41 (+1.15%) 02/07/23 Vertex options imply 3.7% move in share price post-earnings 11/28/22 Early notable gainers among liquid option names on November 28th
Conference/Events	Roper Technologies to hold an investor day » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 ROP Roper Technologies $432.43 / +6.74 (+1.58%) Investor Day to be held… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ROP Roper Technologies $432.43 / +6.74 (+1.58%) 01/04/23 PowerPlan launches Data Hub APIs 11/23/22 CFO of Roper Technologies Crisci sells $2.6M in company shares 11/15/22 Roper Technologies announces transition plan for CFO 11/10/22 Roper Technologies raises dividend 10% to 68.25c per share ROP Roper Technologies $432.43 / +6.74 (+1.58%) 03/20/23 Baird Roper Technologies assumed with a Neutral at Baird 03/20/23 Truist Roper Technologies initiated with a Buy at Truist 02/23/23 Wolfe Research Roper Technologies upgraded to Outperform from Peer Perform at Wolfe Research 10/27/22 Wells Fargo Roper Technologies price target raised to $540 from $500 at Wells Fargo ROP Roper Technologies $432.43 / +6.74 (+1.58%) 01/27/23 Roper Technologies sees Q1 adjusted EPS $3.80-$3.84, consensus $3.82 01/27/23 Roper Technologies sees FY23 adjusted EPS $15.90-$16.20, consensus $15.95 01/27/23 Roper Technologies reports Q4 adjusted EPS $3.92, consensus $3.77 10/26/22 Roper Technologies raises FY22 adj. EPS view to $14.09-$14.13 from $13.46-$13.62 ROP Roper Technologies $432.43 / +6.74 (+1.58%) 02/21/23 Fly Insider: Roper, Aflac among week's notable insider trades 08:30 Today Roper Technologies
Conference/Events	Glacier Bancorp participates in a conference call with DA Davidson » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 GBCI Glacier Bancorp $41.79 / +0.57 (+1.38%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events GBCI Glacier Bancorp $41.79 / +0.57 (+1.38%) 02/21/23 Raymond James Glacier Bancorp upgraded to Outperform from Market Perform at Raymond James 02/21/23 Raymond James Glacier Bancorp upgraded to Outperform from Market Perform at Raymond James 02/01/23 Truist Glacier Bancorp price target lowered to $50 from $62 at Truist 12/09/22 Truist Glacier Bancorp price target lowered to $62 from $68 at Truist GBCI Glacier Bancorp $41.79 / +0.57 (+1.38%) 01/26/23 Glacier Bancorp reports Q4 EPS 72c, consensus 73c 10/20/22 Glacier Bancorp reports Q3 EPS 72c, consensus 73c 13:00 Today Glacier Bancorp - GBCI 04/26/23 Glacier Bancorp
Conference/Events	Brink's management to meet with Truist » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 BCO Brink's $61.30 / +0.69 (+1.14%) Meetings to be held with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BCO Brink's $61.30 / +0.69 (+1.14%) 10/03/22 Brink's acquires NoteMachine for $179M BCO Brink's $61.30 / +0.69 (+1.14%) 08/01/22 Truist Brink's price target lowered to $78 from $96 at Truist BCO Brink's $61.30 / +0.69 (+1.14%) 02/22/23 Brink's sees FY23 adjusted EPS $6.30-$7.00, two estimates $6.53 02/22/23 Brink's reports Q4 adjusted EPS $2.10 vs. $1.68 a year ago 10/26/22 Brink's narrows FY22 adjusted EPS view to $5.75 from $5.50-$6.00 10/26/22 Brink's reports Q3 adjusted EPS $1.34 vs $1.14 last year BCO Brink's $61.30 / +0.69 (+1.14%) 03/20/23 Fly Insider: Southwest Gas, Pathward among week's notable insider trades 00:00 Today Brink's 03/22/23 Brink's 05/05/23 The Brink's Company
Conference/Events	Five Below management to meet virtually with Loop Capital » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 FIVE Five Below $199.16 / +6.09 (+3.15%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options FIVE Five Below $199.16 / +6.09 (+3.15%) 03/15/23 Five Below falls 4% to $189.99 after Q4 results, below-consensus guidance 03/15/23 Five Below sees FY23 comparable sales up 1%-4% 03/15/23 Five Below sees Q1 comparable sales up 2.5%-4% 03/13/23 Five Below promotes Kenneth Bull to COO FIVE Five Below $199.16 / +6.09 (+3.15%) 03/20/23 Citi Five Below price target raised to $225 from $220 at Citi 03/16/23 Deutsche Bank Five Below price target raised to $238 from $234 at Deutsche Bank 03/16/23 Truist Five Below price target raised to $224 from $217 at Truist 03/16/23 Loop Capital Five Below price target raised to $190 from $175 at Loop Capital FIVE Five Below $199.16 / +6.09 (+3.15%) 03/15/23 Five Below sees FY23 EPS $5.25-$5.76, consensus $5.67 03/15/23 Five Below sees Q1 EPS 59c-65c, consensus 68c 03/15/23 Five Below reports Q4 EPS $3.07, consensus $3.07 01/09/23 Five Below sees Q4 and FY22 'near high end of prior guidance ranges' FIVE Five Below $199.16 / +6.09 (+3.15%) 03/16/23 What You Missed On Wall Street On Thursday 03/16/23 What You Missed On Wall Street This Morning 03/15/23 Fly Intel: After-Hours Movers 02/18/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/28/23 Northland Hosted Company Meetings at 2023 Enterprise Connect Conference 00:00 Today Five Below 04/05/23 Five Below FIVE Five Below $199.16 / +6.09 (+3.15%) 03/15/23 Five Below options imply 6.1% move in share price post-earnings 11/30/22 Five Below options imply 7.2% move in share price post-earnings
Conference/Events	Lincoln Educational management to meet with Lake Street » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 LINC Lincoln Educational $5.16 / -0.17 (-3.19%) Meeting to be held with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LINC Lincoln Educational $5.16 / -0.17 (-3.19%) 11/30/22 Lincoln Educational reports mandatory conversion of Series A stock 11/10/22 Lincoln Educational introduces medical assistant training at East Windsor campus LINC Lincoln Educational $5.16 / -0.17 (-3.19%) 09/08/22 Rosenblatt Rosenblatt starts Lincoln Educational at Buy on 'compelling' risk/reward 09/08/22 Rosenblatt Lincoln Educational initiated with a Buy at Rosenblatt 08/08/22 Barrington Lincoln Educational price target lowered to $8.50 from $9.50 at Barrington 06/30/22 Lake Street Lincoln Educational initiated with a Buy at Lake Street LINC Lincoln Educational $5.16 / -0.17 (-3.19%) 02/27/23 Lincoln Educational sees 2023 revenue $345M-$360M, consensus $351.83M 02/27/23 Lincoln Educational reports Q4 EPS 27c, consenus 26c 11/07/22 Lincoln Educational reiterates FY22 revenue $340M-$350M, consensus $345.23M 11/07/22 Lincoln Educational reports Q3 EPS 10c, consensus 10c 00:00 Today Lincoln Educational

Conference/Events	Ryan Specialty Group management to meet with William Blair » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) 03/15/23 Ryan Specialty Group CEO buys $7.78M in common stock 01/03/23 Ryan Specialty Group completes acquisition of Griffin Underwriting Services 12/12/22 Ryan Specialty Group to acquire assets of Griffin Underwriting Services 11/17/22 Ryan Specialty Group CEO buys $6.36M in common stock RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) 02/21/23 Autonomous Ryan Specialty Group initiated with an Underperform at Autonomous 01/19/23 BMO Capital Ryan Specialty Group initiated with an Outperform at BMO Capital 12/16/22 Wells Fargo Ryan Specialty Group upgraded to Overweight from Equal Weight at Wells Fargo 12/14/22 Citi Citi expands P&C insurance coverage with Arthur J. Gallagher top pick RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) 02/28/23 Ryan Specialty Group sees FY23 organic revenue growth 10%-13%, consensus $2B 02/28/23 Ryan Specialty Group reports Q4 adjusted EPS 27c, consensus 26c 11/10/22 Ryan Specialty Group reports Q3 adjusted EPS 25c, consensus 26c RYAN Ryan Specialty Group $38.04 / -0.2 (-0.52%) 11/28/22 Fly Insider: Autoscope, Archer Aviation among week's notable insider trades 11/11/22 What You Missed On Wall Street On Friday 11/11/22 What You Missed On Wall Street This Morning 00:00 Today Ryan Specialty Group
Conference/Events	Northeast Bank management to meet with Piper Sandler » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 NBN Northeast Bank $37.87 / -0.07 (-0.18%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NBN Northeast Bank $37.87 / -0.07 (-0.18%) 12/12/22 Northeast Bank announces commencement of at-the-market offering NBN Northeast Bank $37.87 / -0.07 (-0.18%) 12/09/22 Piper Sandler Northeast Bank price target raised to $60 from $46 at Piper Sandler NBN Northeast Bank $37.87 / -0.07 (-0.18%) 10/31/22 Northeast Bancorp reports Q1 EPS $1.12 vs $1.20 last year 00:00 Today Northeast Bank
Conference/Events	ASGN management to meet with William Blair » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 ASGN ASGN $80.79 / +0.265 (+0.33%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ASGN ASGN $80.79 / +0.265 (+0.33%) 10/03/22 ASGN acquires Iron Vine Security, terms undisclosed ASGN ASGN $80.79 / +0.265 (+0.33%) 02/09/23 Baird ASGN price target lowered to $103 from $108 at Baird 08/08/22 BofA ASGN price target raised to $122 from $120 at BofA 07/29/22 BMO Capital ASGN price target raised to $105 from $94 at BMO Capital 06/14/22 Truist ASGN price target lowered to $110 from $150 at Truist ASGN ASGN $80.79 / +0.265 (+0.33%) 02/08/23 ASGN sees Q1 adjusted EPS $1.37-$1.45, consensus $1.49 02/08/23 ASGN reports Q4 adjusted EPS $1.51, consensus $1.49 10/26/22 ASGN sees Q4 adjusted EPS $1.44-$1.51, consensus $1.62 10/26/22 ASGN reports Q3 adjusted EPS $1.79, consensus $1.78 00:00 Today ASGN
Conference/Events	Perion Network management to meet virtually with Oppenheimer » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 PERI Perion Network $35.21 / -0.26 (-0.73%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PERI Perion Network $35.21 / -0.26 (-0.73%) 02/08/23 Perion Network announces six-month CEO transition period PERI Perion Network $35.21 / -0.26 (-0.73%) 01/30/23 Needham Perion Network price target raised to $37 from $32 at Needham 01/20/23 Lake Street Lake Street 'comfortable' with revenue growth forecast for Perion Network PERI Perion Network $35.21 / -0.26 (-0.73%) 02/08/23 Perion Network sees FY23 revenue $720M-$740M, consensus $730.03M 02/08/23 Perion Network reports Q4 adjusted EPS 90c, consensus 59c 01/04/23 Perion Network reports preliminary FY22 revenue $636M, consensus $632.26.6M 01/04/23 Perion Network reports preliminary Q4 revenue $205M, consensus $201.6M PERI Perion Network $35.21 / -0.26 (-0.73%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 10/06/22 What You Missed On Wall Street On Thursday 00:00 Today Perion Network PERI Perion Network $35.21 / -0.26 (-0.73%) 12/09/22 Largest borrow rate increases among liquid names 12/06/22 Largest borrow rate increases among liquid names 11/25/22 Largest borrow rate increases among liquid names
Conference/Events	Acutus Medical management to meet virtually with BTIG » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 AFIB Acutus Medical / + Medical Technology and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AFIB Acutus Medical / + 02/06/23 Acutus Medical reports results from AcQForce Flutter Study 01/09/23 Acutus Medical names Takeo Mukai as CFO 12/29/22 Acutus Medical says AcQForce Flutter abstract accepted for presentation 12/21/22 Acutus Medical achieves second milestone under agreement with Medtronic AFIB Acutus Medical / + 03/17/23 Canaccord Acutus Medical price target lowered to $1.00 from $1.91 at Canaccord 06/24/22 BTIG Acutus Medical price target lowered to $1.50 from $2.00 at BTIG 04/27/22 BTIG Acutus Medical upgraded to Buy from Neutral at BTIG AFIB Acutus Medical / + 03/16/23 Acutus Medical sees FY23 revenue $18M-$21M, consensus $20.46M 03/16/23 Acutus Medical reports Q4 EPS (63c), consensus (71c) 01/09/23 Acutus Medical sees FY22 revenue $16.1M-$16.3M, consensus $15.7M 01/09/23 Acutus Medical sees Q4 revenue $4.7M-$4.9M, consensus $4.15M 03/22/23 March Small-Cap Virtual Conference 00:00 Today Acutus Medical
Conference/Events	Northwest Pipe management to meet virtually with Northland » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 NWPX Northwest Pipe $31.59 / +0.015 (+0.05%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NWPX Northwest Pipe $31.59 / +0.015 (+0.05%) 11/22/22 Northwest Pipe to manufacture engineered steel pressure Texas pipeline project NWPX Northwest Pipe $31.59 / +0.015 (+0.05%) 01/23/23 Northland Northwest Pipe initiated with an Outperform at Northland NWPX Northwest Pipe $31.59 / +0.015 (+0.05%) 03/15/23 Northwest Pipe reports Q4 adjusted EPS 85c vs. 67c last year 03/22/23 March Small-Cap Virtual Conference 12:15 Today Northwest Pipe - NWPX 10:00 Today Northwest Pipe
Conference/Events	Franklin BSP Realty Trust management to meet with B. Riley » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 FBRT Franklin BSP Realty Trust $11.83 / +0.245 (+2.11%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events FBRT Franklin BSP Realty Trust $11.83 / +0.245 (+2.11%) 09/28/22 B. Riley Franklin BSP Realty Trust initiated with Buy, $16 target at B. Riley 09/28/22 B. Riley Franklin BSP Realty Trust initiated with a Buy at B. Riley 08/18/22 JMP Securities Franklin BSP downgraded to Market Perform from Outperform at JMP Securities 04/08/22 JonesTrading Franklin BSP Realty Trust initiated with a Buy at JonesTrading FBRT Franklin BSP Realty Trust $11.83 / +0.245 (+2.11%) 02/22/23 Franklin BSP Realty Trust reports Q4 distributable EPS 37c, consensus 36c 00:00 Today Franklin BSP Realty Trust
Conference/Events	Sonic Automotive management to meet with Stephens » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 SAH Sonic Automotive $50.82 / +1.32 (+2.67%) Analyst Imbro holds… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SAH Sonic Automotive $50.82 / +1.32 (+2.67%) 02/28/23 Sonic Automotive promotes Angela Broadway to Chief Human Resources Officer 02/15/23 Sonic Automotive acquires Black Hills Harley-Davidson, terms not disclosed 10/28/22 Sonic Automotive identified material weakness in certain internal controls 10/27/22 Sonic Automotive raises quarterly dividend 12% to 28c per share SAH Sonic Automotive $50.82 / +1.32 (+2.67%) 02/21/23 JPMorgan Sonic Automotive downgraded to Neutral from Overweight at JPMorgan 12/27/22 Morgan Stanley Used car prices still have room to decrease 'significantly,' says Morgan Stanley 10/31/22 Benchmark Sonic Automotive price target lowered to $62 from $71 at Benchmark 10/06/22 JPMorgan Sonic Automotive upgraded to Overweight from Neutral at JPMorgan SAH Sonic Automotive $50.82 / +1.32 (+2.67%) 02/15/23 Sonic Automotive reports Q4 adjusted EPS $2.61, consensus $2.22 10/27/22 Sonic Automotive reports Q3 EPS $2.23, consensus $2.47 00:00 Today Sonic Automotive 03/22/23 Sonic Automotive
Conference/Events	Embecta management to meet with Mizuho » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 EMBC Embecta $29.67 / -0.155 (-0.52%) Meeting to be held on the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EMBC Embecta $29.67 / -0.155 (-0.52%) 01/25/23 Embecta opens new global headquarters in Parsippany, New Jersey EMBC Embecta $29.67 / -0.155 (-0.52%) 01/06/23 Morgan Stanley Morgan Stanley cuts 'longer-term execution story' Embecta to Underweight 01/06/23 Morgan Stanley Embecta downgraded to Underweight from Equal Weight at Morgan Stanley 09/08/22 BTIG Embecta initiated with a Neutral at BTIG 08/01/22 Morgan Stanley Embecta initiated with an Equal Weight at Morgan Stanley EMBC Embecta $29.67 / -0.155 (-0.52%) 02/14/23 Embecta reports Q1 adjusted EPS 96c, consensus 51c 12/20/22 Embecta sees FY23 adjusted EPS $1.75-$2.00, consensus $3.11 12/20/22 Embecta reports Q4 EPS (30c), consensus 66c EMBC Embecta $29.67 / -0.155 (-0.52%) 12/20/22 What You Missed On Wall Street On Tuesday 12/20/22 What You Missed On Wall Street This Morning 12/20/22 Fly Intel: Pre-market Movers 00:00 Today Embecta
Hot Stocks	CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 CVI CVR Energy $30.55 / +0.77 (+2.59%) , AAWW Atlas Air $102.49 / + (+0.00%) , APO Apollo Global $56.82 / +0.25 (+0.44%) Apollo Global Management… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CVI AAWW APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 03/16/23 KBR's K-SAAT technology selected by CVR Energy 03/15/23 CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 02/14/23 Icahn boosts stake in Crown Holdings, reduces stake in Cheniere Energy 01/22/23 Fly Intel: Top five weekend stock stories AAWW Atlas Air $102.49 / + (+0.00%) 03/17/23 AAR Corp. elects Dietrich to its board of directors 03/15/23 CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 03/14/23 Atlas Air expects to consummate Apollo merger on or about March 17 02/01/23 Atlas Air takes delivery of final 747 to be produced by Boeing APO Apollo Global $56.82 / +0.25 (+0.44%) 03/15/23 CVR Energy to replace Atlas Air in S&P 600 at open on 3/21 03/14/23 Atlas Air expects to consummate Apollo merger on or about March 17 03/14/23 Univar to be acquired by Apollo Global funds for $8.1B 03/14/23 Univar jumps 14% after WSJ reports Apollo to buy company for $8.1B CVI AAWW APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 03/08/23 UBS UBS starts eight independent refiners with three Buys 03/08/23 UBS CVR Energy initiated with a Neutral at UBS 09/15/22 Wolfe Research Wolfe downgrades CVR Energy, says bull thesis played out 09/14/22 Wolfe Research CVR Energy downgraded to Peer Perform from Outperform at Wolfe Research AAWW Atlas Air $102.49 / + (+0.00%) 08/09/22 Loop Capital Atlas Air downgraded to Hold from Buy at Loop Capital 08/05/22 Susquehanna Atlas Air downgraded to Neutral from Positive at Susquehanna 08/03/22 Stifel Atlas Air downgraded to Hold from Buy at Stifel 08/03/22 Wolfe Research Atlas Air upgraded to Peer Perform from Underperform at Wolfe Research APO Apollo Global $56.82 / +0.25 (+0.44%) 02/10/23 Keefe Bruyette Apollo Global upgraded to Outperform from Market Perform at Keefe Bruyette 01/31/23 BMO Capital Franklin Resources price target raised to $23 from $22 at BMO Capital 01/12/23 Barclays Apollo Global price target raised to $85 from $78 at Barclays 01/02/23 Keefe Bruyette Apollo Global downgraded to Market Perform from Outperform at Keefe Bruyette CVI AAWW APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 02/21/23 CVR Energy reports Q4 adjusted EPS $1.68, consensus $1.48 10/31/22 CVR Energy reports Q3 adjusted EPS $1.90, consensus $1.90 AAWW Atlas Air $102.49 / + (+0.00%) 02/23/23 Atlas Air reports Q4 EPS $5.17, consensus $5.20 11/03/22 Atlas Air reports Q3 adjusted EPS $2.69, consensus $4.26 APO Apollo Global $56.82 / +0.25 (+0.44%) 02/09/23 Apollo Global reports Q4 adjusted EPS $1.42, consensus $1.50 02/08/23 Notable companies reporting before tomorrow's open 02/08/23 Notable companies reporting before tomorrow's open 11/02/22 Apollo Global reports Q3 EPS ($1.52) vs. $1.01 last year CVI AAWW APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 01/21/23 Wells Fargo, Disney among stocks watched by value investors, Barron's says AAWW Atlas Air $102.49 / + (+0.00%) 10/12/22 Wheel falls off Boeing 747 cargo plane after takeoff, Bloomberg reports APO Apollo Global $56.82 / +0.25 (+0.44%) 03/14/23 Buyout titans weighing purchases from SVB loan book, FT reports 03/14/23 Apollo Global agrees to buy Univar for $8.1B including debt, WSJ reports 03/13/23 Apollo Global looking at Silicon Valley Bank book of loans, Bloomberg reports 03/13/23 Apollo Global looking at Silicon Valley Bank assets, Bloomberg reports CVI APO CVI CVR Energy $30.55 / +0.77 (+2.59%) 03/15/23 Fly Intel: After-Hours Movers APO Apollo Global $56.82 / +0.25 (+0.44%) 03/14/23 What You Missed On Wall Street On Tuesday 03/14/23 What You Missed On Wall Street This Morning 03/14/23 Fly Intel: Pre-market Movers 03/04/23 Buy/Sell: Wall Street's top 10 stock calls this week AAWW APO AAWW Atlas Air $102.49 / + (+0.00%) 01/26/23 Unusually active option classes on open January 26th APO Apollo Global $56.82 / +0.25 (+0.44%) 01/09/23 Apollo Global put volume heavy and directionally bearish 12/28/22 Apollo Global put volume heavy and directionally bearish 12/22/22 Apollo Global put volume heavy and directionally bearish 12/07/22 Apollo Global put volume heavy and directionally bearish

Conference/Events	Avid Technology management to meet virtually with Northland » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 AVID Avid Technology $28.98 / +0.3 (+1.05%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AVID Avid Technology $28.98 / +0.3 (+1.05%) 02/16/23 Avid Technology announces new Pro Tools Scripting SDK 11/30/22 TV MIDTVEST expands strategic relationship with Avid Technology 11/28/22 Avid Technology appoints Deb Sanders as CCO 10/13/22 Avid Technology announces amended credit facility AVID Avid Technology $28.98 / +0.3 (+1.05%) 03/06/23 Truist Avid Technology initiated with a Buy at Truist 08/03/22 B. Riley Avid Technology price target lowered to $34 from $45 at B. Riley 07/11/22 Rosenblatt Avid Technology initiated with a Neutral at Rosenblatt 07/06/22 JPMorgan Avid Technology initiated with an Overweight at JPMorgan AVID Avid Technology $28.98 / +0.3 (+1.05%) 03/01/23 Avid Technology sees FY23 EPS $1.53-$1.75, consensus $1.63 03/01/23 Avid Technology sees Q1 EPS 21c-29c, consensus 31c 03/01/23 Avid Technology reports Q4 EPS 45c, consensus 48c 11/08/22 Avid Technology sees FY22 adjusted EPS $1.40-$1.50, consensus $1.44 AVID Avid Technology $28.98 / +0.3 (+1.05%) 03/01/23 Fly Intel: After-Hours Movers 11/08/22 Fly Intel: After-Hours Movers 09:30 Today Avid Technology
Conference/Events	Brixmor management to meet with KeyBanc » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 BRX Brixmor $20.50 / +0.465 (+2.32%) Meetings to be held with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BRX Brixmor $20.50 / +0.465 (+2.32%) 02/03/23 Brixmor chair John Schreiber to retire, Crosland named next chair BRX Brixmor $20.50 / +0.465 (+2.32%) 12/16/22 Wolfe Research Brixmor upgraded to Outperform at Wolfe Research on steady internal growth 12/15/22 Wolfe Research Brixmor upgraded to Outperform from Peer Perform at Wolfe Research 12/15/22 Piper Sandler Federal Realty downgraded to Neutral from Overweight at Piper Sandler 12/06/22 Barclays Brixmor price target raised to $28 from $26 at Barclays BRX Brixmor $20.50 / +0.465 (+2.32%) 02/13/23 Brixmor sees 2023 FFO $1.95-$2.03, consensus $2.01 02/13/23 Brixmor reports Q4 FFO 49c, consensus 49c 11/01/22 Brixmor sees FY22 NAREIT FFO $1.94-$1.97, consensus $1.96 11/01/22 Brixmor reports Q3 NAREIT FFO 49c, consensus 49c 05/11/23 2023 Real Estate Summit 05/02/23 Brixmor - BRX 00:00 Today Brixmor 03/22/23 Brixmor 04/26/23 Brixmor Property Group Inc.
Conference/Events	Consol Energy management to meet with Benchmark » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 CEIX Consol Energy $53.11 / -0.2 (-0.38%) Analyst Martin holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events CEIX Consol Energy $53.11 / -0.2 (-0.38%) 03/01/23 Einhorn discusses Tenet, Consol, Teck Resources longs on CNBC 02/14/23 Greenlight buys Tenet, exits Intel in Q4 12/02/22 Consol Energy CEO sells $1.2M in common stock 11/14/22 Greenlight takes new stake in Intel, exits position in Atlas Air CEIX Consol Energy $53.11 / -0.2 (-0.38%) 01/17/23 B. Riley Consol Energy price target lowered to $84 from $85 at B. Riley 11/02/22 Benchmark Consol Energy price target raised to $80 from $72 at Benchmark 11/02/22 B. Riley Consol Energy price target raised to $85 from $80 at B. Riley 10/11/22 B. Riley Consol Energy price target raised to $80 from $79 at B. Riley 00:00 Today Consol Energy
Conference/Events	Eagle Bulk Shipping management to meet with B. Riley » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 EGLE Eagle Bulk Shipping $45.14 / -0.175 (-0.39%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EGLE Eagle Bulk Shipping $45.14 / -0.175 (-0.39%) 03/03/23 Eagle Bulk Shipping falls -15.0% 03/03/23 Eagle Bulk Shipping falls -11.7% 03/03/23 Eagle Bulk Shipping falls -11.4% 01/19/23 Eagle Bulk Shipping appoints Kate Blankenship to board EGLE Eagle Bulk Shipping $45.14 / -0.175 (-0.39%) 01/30/23 Fearnley Eagle Bulk Shipping upgraded to Buy from Hold at Fearnley 01/23/23 BTIG Eagle Bulk Shipping price target raised to $70 from $60 at BTIG 10/10/22 B. Riley Eagle Bulk Shipping price target lowered to $72 from $82 at B. Riley 09/29/22 Stifel Eagle Bulk Shipping initiated with a Buy at Stifel EGLE Eagle Bulk Shipping $45.14 / -0.175 (-0.39%) 03/02/23 Eagle Bulk Shipping reports Q4 adjusted EPS $2.76, consensus $2.99 11/03/22 Eagle Bulk Shipping reports Q3 adjusted EPS $4.58, consensus $4.70 00:00 Today Eagle Bulk Shipping
Conference/Events	Hannon Armstrong to hold an virtual investor day » 04:55 03/21/23 03/21 04:55 03/21/23 04:55 HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) Virtual Investor Day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) 03/20/23 Hannon Armstrong invests $30M in Bioenergy Devco 02/16/23 Hannon Armstrong names Jeffrey Lipson president, CEO 02/16/23 Hannon Armstrong backs annual EPS CAGR view 10%-13% 01/04/23 Hannon Armstrong Invests in a 1.3 GW renewables portfolio operated by AES HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) 02/23/23 Cowen Hannon Armstrong price target lowered to $41 from $44 at Cowen 02/17/23 JPMorgan Hannon Armstrong price target lowered to $52 from $56 at JPMorgan 01/25/23 BofA Hannon Armstrong upgraded to Neutral at BofA on balance sheet acceleration 01/24/23 BofA Hannon Armstrong upgraded to Neutral from Underperform at BofA HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) 02/16/23 Hannon Armstrong reports Q4 distributable EPS 47c, consensus 49c 11/03/22 Hannon Armstrong reports Q3 distributable EPS 49c, consensus 49c HASI Hannon Armstrong $23.98 / +0.09 (+0.38%) 02/13/23 What You Missed This Week in EVs and Clean Energy 01/25/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:30 Today Hannon Armstrong

Events

Earnings calls, analyst events, roadshows and more

TME
Today at 07:00

Tencent Music - TME Conference Calls
CSIQ
Today at 08:00

Canadian Solar - CSIQ Conference Calls
HUYA
Today at 08:00

Huya - HUYA Conference Calls
ONON
Today at 08:00

On Holding - ONON Conference Calls
INKT
Today at 08:30

MiNK Therapeutics - INKT Conference Calls
LMDX
Today at 08:30

LumiraDx - LMDX Conference Calls
HASI
Today at 08:30

Hannon Armstrong Firm Sponsored Meetings

Virtual Meeting
ROP
Today at 08:30

Roper Technologies Firm Sponsored Meetings

Ritz-Carlton Hotel, New York, NY
CTRN
Today at 09:00

Citi Trends - CTRN Conference Calls
OXSQ
Today at 09:00

Oxford Square Capital - OXSQ Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	MGRX X MGRX Mangoceuticals IPO Managers: Boustead $4.00 1.25M Shares
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs, JPMorgan, Morgan Stanley $182.50 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Brixmor chair John Schreiber to retire, Crosland named next chair

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access